The Department of Nuclear Medicine is a department that uses radioactive isotopes to diagnose or treat our condition and disease. In the imaging test, a radioactive isotope reflecting the physiological metabolism is injected into the human body, and the distribution is visualized to diagnose the illness. Nuclear medicine treats the condition by collecting the radioactive isotope in the diseased area and using radiation from the element. Besides, we test specimens for the diagnosis of disease by precisely measuring the number of trace substances in blood or body fluids of patients with radioactive isotopes.
Unlike computed tomography (CT) and magnetic resonance imaging (MRI), which are tests for diagnosing through anatomical morphology, positron emission tomography (PET), a representative image test of the nuclear medicine department, has high sensitivity and specificity for the diagnosis of primary or metastatic cancer by diagnosing biochemical metabolism, functional changes, etc.
PET / CT is a state-of-the-art diagnostic test that can more easily grasp the anatomical location and change of disease by fusing CT images to PET images. In addition, various kinds of nuclear medicine scans and single-photon emission computed tomography (SPECT) examination are used in multiple diseases. Thyroid cancer is one of the most common illnesses treated in the department of nuclear medicine. Diagnosis and treatment with radioactive iodine is the most effective method for the discovery of recurrence or metastasis after surgery, treatment of recurrence or metastatic cancer. Therefore, despite the high incidence of thyroid cancer, the treatment outcome is excellent, with a 10-year survival rate of more than 90%. Also, diagnosis and treatment using nuclear medicine carried out in various diseases such as neurological diseases, degenerative brain diseases such as Kinson's disease, and Alzheimer's disease, including cancer, cardiovascular, cerebrovascular diseases.
* TEL : 650-4323